See more
Medical Affairs
14 nov, 2025
Myocardial revascularization in patients with acute myocardial infarction (AMI) and multivessel coronary artery disease remains a topic of ongoing debate, particularly regarding the benefit of treating only the culprit lesion versus performing complete revascularization. Previous clinical trials suggested a reduction in nonfatal events with a complete approach, but uncertainty persisted regarding its effect on cardiovascular and all-cause mortality. </
3 min read
13 nov, 2025
Beta-blocker therapy has long been considered the standard of care following acute myocardial infarction (MI). However, its role in patients with preserved ejection fraction (LVEF ≥50%) and without heart failure remains uncertain in modern practice, where most patients undergo early reperfusion and receive optimized medical therapy. The individual patient data meta-analysis</stro
The DECAF randomized clinical trial evaluated the impact of daily caffeinated coffee consumption versus complete abstinence from coffee and caffeine for six months in patients with atrial fibrillation. Atrial fibrillation is the most common sustained arrhythmia, associated with significant morbidity, and recurrence after cardioversion remains a clinical challenge, highlighti
Show more
